Loading…
Based on limited metadata without access to the full letter text, this FDA Warning Letter issued to PharmaMedics on August 16, 2018 concerns an "Other" product category, though the specific nature of violations cannot be determined as no subject line was provided. The issuing office information is unavailable, limiting clarity on which FDA division or center initiated the warning. Without the complete letter, the specific regulatory concerns and violation count remain unknown, though the warning indicates PharmaMedics was found to have compliance issues significant enough to warrant FDA enforcement action.